Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB-742457 versus donepezil versus placebo in mild to moderate Alzheimer's disease
2006-000468-95Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing SB-742457, donepezil and placebo (3 arms). Primary endpoint: Change from baseline to Week 24 in Alzheimer's Disease Assessment Scale cognitive subscale total score. Started Mar 2006; status: completed.
02
Drugs
intepirdinedonepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2006-000468-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000468-95.